Circadian variation in blood pressure: Implications for the elderly patient

American Journal of Hypertension

Volumn 12, Issue 2 SUPPL. 1, 1999, Pages 43S-49S

  Elliott, William J ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diurnal variation; Elderly; Hypertension; Nocturnal decline; Silent cerebral damage

Indexed keywords

ACUTE HEART INFARCTION; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0033005580     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00279-9     Document Type: Article

References (23)

1. Muller JE, Abela GS, Nesto RW, Tofler GH: Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994;23:809-813.
2. Staessen JA, Bieniaszewski L, O'Brien E, et al: Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997;29:30-39.
3. Martens PR, Calle P, Van den Poel B, et al for the Belgian Cardiopulmonary Cerebral Resuscitation Study Group: Further prospective evidence of a circadian variation in the frequency of call for sudden cardiac death. Intensive Care Med 1995;21:45-49.
4. Cohen MC, Ruhtla KM, Lavery CE, et al: Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997;79:1512-1516.
5. Elliott WJ: Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998;29:992-996.
6. Millar-Craig MW, Bishop CN, Raftery EB: Circadian variation of blood-pressure. Lancet 1978;i:795-797.
7. Fromm RE Jr, Levine RL, Pepe PE: Circadian variation in the time of request for helicopter transport of cardiac patients. Ann Emerg Med 1992;21:1196-1199.
8. Kario K, Matsuo T, Kobayashi H, et al: Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-135.
9. Schneider R, Wieczorek V: Historical aspects of neuroscience: Otto Binswanger (1852-1929). J Neurol Sci 1991;103:61-64.
10. Kohara K, Igase M, Yinong J, et al: Asymptomatic cerebrovascular damages in essential hypertension in the elderly. Am J Hypertens 1997;10:829-835.
11. Kario K, Motai K, Mitsuhashi T, et al: Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: relation to silent cerebrovascular disease. Hypertension 1997;30:1504-1510.
12. Hattenhauer MG, Leavitt JA, Hodge DO, et al: Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:103-107.
13. Hayreh SS: Pathogenesis of optic nerve damage and visual field defects, in Heilmann K, Richardson KT (eds): Glaucoma: Conceptions of Disease. Thieme, Stuttgart, 1978, pp 104-137, 405-411.
14. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM: Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-624.
15. Hayreh SS, Podhajsky PA, Zimmerman B: Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997;124:641-647.
16. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL: Nonarteritic anterior optic ischemic neuropathy: role of nocturnal arterial hypotension (letter). Arch Ophthalmol 1997;115:942-945.
17. Landau K, Winterkorn JM, Mailloux LU, et al: 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114: 570-575.
18. Palatini P: Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? Am Heart J 1992;123:1421-1425.
19. Covera-HS package insert. G.D. Searle & Co., 1998
20. Gupta SK, Yih BM, Atkinson L, Longstreth J: The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamic of verapamil and norverapamil. J Clin Pharmacol 1995;35:1083-1093.
21. White WB, Black HR, Weber MA, et al: Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol 1998;81:424-431.
22. Williams GH, Anderson RB, Hollenberg NK, et al: Symptoms and the distress they cause during antihypertensive therapy: comparison of calcium channel blockade with nifedipine GITS and COER-verapamil (abst). Am J Hypertens 1997;10:84A.
23. Black HR, Elliott WJ, Neaton JD, et al, for the CONVINCE Research Group: Rationale and design of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Controlled Clinical Trials 1998;19:370-390.